CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 107 filers reported holding CULLINAN ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 2.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $935,018 | +339.1% | 103,317 | +422.1% | 0.00% | – |
| Q2 2023 | $212,919 | -75.9% | 19,788 | -77.0% | 0.00% | – |
| Q1 2023 | $881,836 | +19.7% | 86,201 | +23.4% | 0.00% | – |
| Q4 2022 | $736,696 | -8.6% | 69,829 | +11.0% | 0.00% | – |
| Q3 2022 | $806,000 | +119.6% | 62,899 | +119.4% | 0.00% | – |
| Q2 2022 | $367,000 | -22.7% | 28,672 | -36.9% | 0.00% | – |
| Q1 2022 | $475,000 | +6.0% | 45,433 | +56.4% | 0.00% | – |
| Q4 2021 | $448,000 | +114.4% | 29,049 | +213.6% | 0.00% | – |
| Q3 2021 | $209,000 | -44.4% | 9,264 | -36.7% | 0.00% | – |
| Q2 2021 | $376,000 | -61.3% | 14,636 | -37.3% | 0.00% | – |
| Q1 2021 | $972,000 | – | 23,335 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $98,051,000 | 27.24% |
| CHI Advisors LLC | 3,047,609 | $39,070,000 | 14.92% |
| Nextech Invest Ltd. | 1,221,145 | $15,655,000 | 5.28% |
| BVF INC/IL | 7,509,059 | $96,266,000 | 4.65% |
| TANG CAPITAL MANAGEMENT LLC | 609,231 | $7,810,000 | 1.18% |
| Boxer Capital, LLC | 1,074,082 | $13,770,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 213,090 | $2,732,000 | 0.84% |
| Atom Investors LP | 96,880 | $1,242,000 | 0.54% |
| EcoR1 Capital, LLC | 1,169,889 | $14,998,000 | 0.52% |
| Birchview Capital, LP | 45,114 | $578,000 | 0.42% |